Jason Alger - 06 Dec 2023 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Accounting Officer
Signature: /s/Benjamin Landry, as Attorney-in-Fact
Issuer symbol: HCAT
Transactions as of: 06 Dec 2023
Transactions value $: $-16,436
Form type: 4
Filing time: 07 Dec 2023, 18:29:07 UTC
Previous filing: 05 Dec 2023
Next filing: 22 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Sale	$-16,436	-2,177	-4.02%	$7.55	51,927	06 Dec 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2022 in accordance with Rule 10b5-1.